Asia Pacific Facial Injectable Market Size & Outlook
Global Market
Related Markets
Asia Pacific facial injectable market highlights
- The Asia Pacific facial injectable market generated a revenue of USD 3,549.0 million in 2025.
- The market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
- In terms of segment, botulinum toxin (botox) was the largest revenue generating product in 2025.
- PN/PDRN is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 3,549.0 million |
| Market revenue in 2033 | USD 7,126.5 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Botulinum toxin (botox) |
| Fastest growing segment | PN/PDRN |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, PCL, PN/PDRN, Botulinum Toxin (Botox), Exosome |
| Key market players worldwide | AbbVie Inc, Medytox, Merz Pharma, Revance Therapeutics Inc, Galderma, Sinclair Pharma plc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 30.1% of the global facial injectable market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,126.5 million by 2033.
The Asia-Pacific market is also benefiting from regulatory advancements and product innovations, expanding access to high-quality injectables. For instance, in February 2024, EG Bio Co., LTD, a South Korean company, obtained CE Mark certification for its EDEL X HA Dermal Filler, making it available in the European market. This approval highlights Asia's growing role in aesthetic product innovation and global expansion.
The filler’s advanced formulation with lidocaine ensures a comfortable and painless experience, increasing consumer preference for non-surgical facial rejuvenation. With continuous technological advancements and rising aesthetic awareness, the Asia-Pacific region remains a key growth hub for the Facial Injectable Market.
No credit card required*
Publish Date: May 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | www.revance.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | www.sinclairpharma.com/ |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.medytox.com/page/company_en?site_id=en |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
| Galderma | View profile | 10001+ | Lausanne, Vaud, Switzerland, Europe | www.galderma.com |
Asia Pacific Facial Injectable Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Facial Injectable Market Outlook will help companies and investors design strategic landscapes.
Botulinum Toxin (Botox) was the largest segment with a revenue share of 50.88% in 2025.
Horizon Databook has segmented the Asia Pacific facial injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox), exosome covering the revenue growth of each sub-segment from 2021 to 2033.
The Asia-Pacific market is also benefiting from regulatory advancements and product innovations, expanding access to high-quality injectables. For instance, in February 2024, EG Bio Co., LTD, a South Korean company, obtained CE Mark certification for its EDEL X HA Dermal Filler, making it available in the European market. This approval highlights Asia's growing role in aesthetic product innovation and global expansion.
The filler’s advanced formulation with lidocaine ensures a comfortable and painless experience, increasing consumer preference for non-surgical facial rejuvenation. With continuous technological advancements and rising aesthetic awareness, the Asia-Pacific region remains a key growth hub for the Facial Injectable Market.
- Asia Pacific Facial Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
- Exosome
- Asia Pacific Facial Injectable Market Applications Outlook (Revenue, USD Million , 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
- Asia Pacific Facial Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others
Reasons to subscribe to Facial Injectable Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Facial Injectable Market Outlook databook
- Our clientele includes a mix of Facial Injectable Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Facial Injectable Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Facial Injectable Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Facial Injectable Market, 2021-2033 (US$M)
Asia Pacific facial injectable market statistics, by product, 2021-2033 (US$M)
